Lauren Santye, Assistant Editor

Combination antibody therapy may lead to new melanoma treatment strategy.

Simian immunodeficiency virus may be able to infect human cells.

Through a shell company, a New York pharmacist improperly billed Medicaid and others $274 million for illegally obtained HIV drugs.

Nusinersen significantly improved motor milestones and muscle function in spinal muscular atrophy (SMA) during phase 3 trial.

Microfluidic device may lead to new treatments for amyotrophic lateral sclerosis and other neuromuscular-related conditions.

Many conventional tests unable to detect resistance to antiretroviral drugs for HIV.

Mutant KRAS gene may lead to new therapies for lung cancer.

Top news of the day from across the health care landscape.

Early treatment of ovarian cancer is vital to survival.

Pharmacy medication synchronization programs may simplify care for diabetes and other chronic conditions.

New direct-acting antivirals show great efficacy and limited side effects treating hepatitis C.

Targeting early marker of insulin resistance shows promise in type 2 diabetes.

Research sheds light on the mechanism behind the development of spinal muscular atrophy (SMA).

Rebekah L. Hanson, PharmD, BCPS, BCACP, clinical pharmacist and assistant professor at UIC College of Pharmacy, discusses how providers can improve patient care through collaboration.

Top news of the day from across the health care landscape.

Monoclonal antibody combination could offer less toxic acute lymphoblastic leukemia treatment.

Novel class of antitumor amphiphilic amines causes death in several cancer cell lines.

Creating standard terminology may improve medication safety and efficacy in precision medicine.

Hepatitis B can lead to liver cancer and cirrhosis.

Opdivo monotherapy for first-line lung cancer unable to meet primary endpoint of progression-free survival.

Athletes from a variety of sports dealt with the hardships of diseases treated by specialty pharmacy.

Top news of the day from across the health care landscape.

Access to care improves among post liver transplant patients.

Updated criteria outlined by ASCO may lead to an increase in the number of breast cancers that test HER2-positive.

System would allow for less painful infusions that do not pierce the skin.

Anti-PD-1 antibodies produced more activated antiviral cells to attack HIV.

Manufacturer coupons found to show significant benefits reducing Sovaldi cost share.

HIV screenings at home and immediate administration of antiretroviral therapy in HIV-positive patients shows promise.

Top news of the day from across the health care landscape.

Pediatric Hodgkin lymphoma survivors are twice as likely to develop cardiovascular disease.